Showing results (21-30 of 63) with videos related to
Sort By:
Pageof 7
The Journal of Rheumatology|April 3, 2012
Interreader reliability in assessment of nailfold capillary abnormalities by beginners: pilot study of an intensive videocapillaroscopy training programMarwin Gutierrez, Chiara Bertolazzi, Marika Tardella, et al.Swiss Medical Weekly|August 25, 2018
The Expanded Risk Score in Rheumatoid Arthritis (ERS-RA): performance of a disease-specific calculator in comparison with the traditional prediction scores in the assessment of the 10-year risk of cardiovascular disease in patients with rheumatoid arthritFausto Salaffi, Marina Carotti, Marco Di Carlo, et al.Medicine|April 21, 2021
Cycling or swap biologics and small molecules in psoriatic arthritis: Observations from a real-life single center cohortAlarico Ariani, Daniele Santilli, Flavio Mozzani, et al.Medicine|March 17, 2021
Mild cognitive impairment in psoriatic arthritis: Prevalence and associated factorsMarco Di Carlo, Andrea Becciolini, Antonella Incorvaia, et al.Rheumatology (Oxford, England)|February 7, 2014
Bone erosions in rheumatoid arthritis: ultrasound findings in the early stage of the diseaseMaria-Magdalena Tămaş, Emilio Filippucci, Andrea Becciolini, et al.Journal of Bodywork and Movement Therapies|November 29, 2025
Validation of the Italian version of the sarcopeniaspecific quality of life questionnaire (SarQoL®)Cosimo Claudio Parente, Roberto Cova, Silvia Faverzani, et al.Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|December 29, 2021
Home-based unsupervised pulmonary rehabilitation program improves the respiratory disability in systemic sclerosis patients with dyspnea: an observational prospective studySilvia Faverzani, Filippo Nocera, Ernesto Crisafulli, et al.Clinical Rheumatology|June 10, 2017
Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differencesEnnio Giulio Favalli, Irene Pontikaki, Andrea Becciolini, et al.Arthritis Care & Research|October 4, 2016
Eight-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Spondyloarthritis: A Multicenter Retrospective AnalysisEnnio Giulio Favalli, Carlo Selmi, Andrea Becciolini, et al.International Journal of Rheumatic Diseases|October 31, 2017
Two-year persistence of golimumab as second-line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real-life data from the LORHEN registryEnnio G Favalli, Luigi Sinigaglia, Andrea Becciolini, et al.Pageof 7